⌘K

Home/Filings/4/0001213900-22-035649

4//SEC Filing

Goodman Tony 4

Accession 0001213900-22-035649

CIK 0001513525other

View on SEC.gov Company Profile

Filed

Jun 27, 8:00 PM ET

Accepted

Jun 28, 6:02 PM ET

Size

5.4 KB

Accession

0001213900-22-035649

Insider Transaction Report

Form 4

Period: 2022-06-27

ADIAL PHARMACEUTICALS, INC.ADIL

DirectorChief Operating Officer

Transactions

Award
Stock Option
2022-06-27+25,000→ 25,000 total
Exercise: $1.23From: 2022-07-27Exp: 2032-06-26→ Common Stock (25,000 underlying)

Footnotes (1)

[F1]The option vests pro rata on a monthly basis over 36 months.

Documents

1 file

4
ownership.xmlPrimary

Issuer

ADIAL PHARMACEUTICALS, INC.

CIK 0001513525

Entity typeother

Related Parties

1

filerCIK 0001717971

Filing Metadata

Form type: 4
Filed: Jun 27, 8:00 PM ET
Accepted: Jun 28, 6:02 PM ET
Size: 5.4 KB

View on SEC.gov